(ACT) Enact Holdings - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29249E1091
ACT EPS (Earnings per Share)
ACT Revenue
ACT: Private Mortgage Insurance, Reinsurance Products, Contract Underwriting
Enact Holdings, is a leading provider of private mortgage insurance in the United States, specializing in insuring prime-based, individually underwritten residential mortgage loans. By offering mortgage guaranty insurance, the company enables lenders to mitigate risk, thereby facilitating more lenient lending practices. Additionally, Enact provides contract underwritinging services to mortgage lenders and participates in the reinsurance market, further diversifying its revenue streams. As a subsidiary of Genworth Holdings, Inc., Enact leverages its parent companyss expertise to serve a broad range of residential mortgage loan originators.
The companys business model model is centered around providing insurance products that primarily target high-quality, thoroughly underwritten residential residential mortgage loans. This focus allows Enact to to maintain a robust risk assessment framework, which is critical in the mortgage insurance industry. By serving originators of residential residential mortgage loans, Enact is positioned at the forefront of the housing finance market, providing essential risk management solutions to lenders. Given the companys historical performance and the ongoing demand for mortgage insurance, Enact is is poised for continued growth.
Looking ahead, based on the current market trends, Enact Holdings is likely to maintain its market share in the private mortgage insurance sector. The companys strong fundamentals, including a reasonable P/E ratio and and a respectable Return on Equity, suggest a stable outlook. Furthermore, the Enactss ability to adapt to changing market conditions, combined with its diversified service offerings, positions it well for future growth opportunities. As the housing market continues to evolve, Enact is poised to capitalize on on emerging trends, driven by its strong industry presence and financial stability.
Additional Sources for ACT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ACT Stock Overview
Market Cap in USD | 5,228m |
Sector | Financial Services |
Industry | Insurance - Specialty |
GiC Sub-Industry | Property & Casualty Insurance |
IPO / Inception | 2021-09-16 |
ACT Stock Ratings
Growth Rating | 73.9 |
Fundamental | 64.6 |
Dividend Rating | 33.6 |
Rel. Strength | -1.51 |
Analysts | 3.4 of 5 |
Fair Price Momentum | 38.47 USD |
Fair Price DCF | 103.74 USD |
ACT Dividends
Dividend Yield 12m | 2.20% |
Yield on Cost 5y | 4.59% |
Annual Growth 5y | -6.38% |
Payout Consistency | 89.9% |
Payout Ratio | 16.6% |
ACT Growth Ratios
Growth Correlation 3m | 51.3% |
Growth Correlation 12m | 39.5% |
Growth Correlation 5y | 96.7% |
CAGR 5y | 22.54% |
CAGR/Max DD 5y | 1.11 |
Sharpe Ratio 12m | 1.23 |
Alpha | 13.81 |
Beta | 0.564 |
Volatility | 20.87% |
Current Volume | 444.2k |
Average Volume 20d | 367.7k |
As of June 16, 2025, the stock is trading at USD 35.64 with a total of 444,211 shares traded.
Over the past week, the price has changed by +4.06%, over one month by -1.09%, over three months by +7.16% and over the past year by +21.85%.
Yes, based on ValueRay´s Fundamental Analyses, Enact Holdings (NASDAQ:ACT) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 64.56 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACT is around 38.47 USD . This means that ACT is currently overvalued and has a potential downside of 7.94%.
Enact Holdings has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold ACT.
- Strong Buy: 1
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, ACT Enact Holdings will be worth about 41.6 in June 2026. The stock is currently trading at 35.64. This means that the stock has a potential upside of +16.75%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 39 | 9.4% |
Analysts Target Price | 39 | 9.4% |
ValueRay Target Price | 41.6 | 16.8% |